Timm Greulich Selected Research

alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency)

1/2021	Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.
11/2011	Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timm Greulich Research Topics

Disease

26	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 03/2011
8	Asthma (Bronchial Asthma) 11/2023 - 03/2011
6	Emphysema 01/2021 - 10/2012
4	Pneumonia (Pneumonitis) 01/2024 - 01/2020
2	Obesity 11/2023 - 09/2021
2	Lung Diseases (Lung Disease) 01/2022 - 03/2011
2	alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency) 01/2021 - 11/2011
2	Inflammation (Inflammations) 01/2020 - 01/2019
1	Malaria 10/2023
1	Blister (Bulla) 01/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Pulmonary Emphysema 01/2023
1	COVID-19 01/2021
1	Disease Progression 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Eosinophilia 01/2018
1	Muscular Dystrophies (Muscular Dystrophy) 01/2017
1	Obstructive Sleep Apnea 01/2017
1	Cardiomyopathies (Cardiomyopathy) 09/2015
1	Heart Failure 09/2015
1	Body Weight (Weight, Body) 01/2015
1	Neoplasms (Cancer) 03/2011
1	Infections 03/2011

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
5	GoldIBA 01/2023 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2017
2	TroponinIBA 01/2024 - 01/2021
2	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2019
2	ProteomeIBA 10/2023 - 01/2020
2	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2021 - 11/2011
2	16S Ribosomal RNAIBA 01/2021 - 01/2017
2	Muscarinic AntagonistsIBA 01/2019 - 01/2017
2	indacaterolIBA 01/2018 - 01/2017
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2018 - 01/2017
2	Bronchodilator Agents (Bronchodilators)IBA 11/2017 - 01/2014
2	GlucocorticoidsIBA 01/2017 - 10/2012
1	CholesterolIBA 01/2024
1	LipidsIBA 01/2024
1	Nicotine FDA Link 01/2024
1	Messenger RNA (mRNA)IBA 01/2024
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 10/2023
1	HLA-DR Antigens (HLA-DR)IBA 10/2023
1	OsteopontinIBA 10/2023
1	InterferonsIBA 09/2021
1	LigandsIBA 09/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2021
1	tiotropium-olodaterolIBA 07/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	CaspasesIBA 01/2020
1	mepolizumabIBA 01/2019
1	AllergensIBA 01/2018
1	Catalytic DNA (Deoxyribozyme)IBA 01/2018
1	Cardiovascular AgentsIBA 11/2017
1	styrene-ethylene-butylene-styrene-block copolymerIBA 01/2017
1	Carbon DioxideIBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2012
1	Volatile Organic CompoundsIBA 11/2011
1	Vitamin D FDA LinkGeneric 03/2011

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2015
1	Precision Medicine 09/2021
1	Palliative Care (Palliative Therapy) 01/2021
1	Self Administration (Administration, Self) 01/2021
1	Length of Stay 05/2020
1	Off-Label Use 01/2019
1	Electronic Nose 11/2011